AB Science Company Top Insiders
| ABSCF Stock | USD 1.45 0.00 0.00% |
AB Science employs about 100 people. The company is managed by 7 executives with a total tenure of roughly 234 years, averaging almost 33.0 years of service per executive, having 14.29 employees per reported executive. Examination of AB Science's management performance can provide insight into the company performance.
| Harshad KULKARNI Insider Head Statistics |
| Alain MBA Insider Chairman, CoFounder |
ABSCF |
AB Science Management Team Effectiveness
The company has return on total asset (ROA) of (0.4329) % which means that it has lost $0.4329 on every $100 spent on assets. This is way below average. AB Science's management efficiency ratios could be used to measure how well AB Science manages its routine affairs as well as how well it operates its assets and liabilities.AB Science SA secures a total of 46.86 Million outstanding shares. AB Science SA shows tangible amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company retains, if the real value of the entity is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as AB Science in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of AB Science, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
AB Science Workforce Comparison
AB Science SA is rated below average in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is presently estimated at about 13,903. AB Science maintains roughly 100.0 in number of employees contributing less than 1% to equities under Drug Manufacturers—Specialty & Generic industry.
AB Science SA Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. AB Science SA Price Series Summation is a cross summation of AB Science price series and its benchmark/peer.
AB Science Notable Stakeholders
An AB Science stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as AB Science often face trade-offs trying to please all of them. AB Science's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting AB Science's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Harshad KULKARNI | Head Statistics | Profile | |
| Alain MBA | Chairman, CoFounder | Profile | |
| Yves MD | Head Pharmacovigilance | Profile | |
| Laurent MBA | Chief Officer | Profile | |
| Alexis BERNARD | Head Sales | Profile | |
| Albert DVM | Pres Operations | Profile | |
| Christian FASSOTTE | Global Officer | Profile |
About AB Science Management Performance
The success or failure of an entity such as AB Science SA often depends on how effective the management is. AB Science management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ABSCF management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ABSCF management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France. Ab Science operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 100 people.
AB Science Workforce Analysis
Traditionally, organizations such as AB Science use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare AB Science within its industry.AB Science Manpower Efficiency
Return on AB Science Manpower
| Revenue Per Employee | 16.1K | |
| Revenue Per Executive | 229.6K | |
| Net Loss Per Employee | 144.6K | |
| Net Loss Per Executive | 2.1M | |
| Working Capital Per Employee | 130K | |
| Working Capital Per Executive | 1.9M |
Complementary Tools for ABSCF Pink Sheet analysis
When running AB Science's price analysis, check to measure AB Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AB Science is operating at the current time. Most of AB Science's value examination focuses on studying past and present price action to predict the probability of AB Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AB Science's price. Additionally, you may evaluate how the addition of AB Science to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |